Biophytis (ALBPS.PA) Stock Price

Biophytis Price

Euronext·CLOSED
0.05
​
Market closed

The consensus 12-month price target for Biophytis is 0.02 EUR, about 68.6% below where the stock trades today. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus.

Biophytis stock price

Access this data via the Eulerpool API

Biophytis business model & stock analysis

Biophytis SA is a holding company, which engages in the clinical development of therapeutics to restore the muscular and visual functions in diseases with significant unmet medical needs. The company is headquartered in Paris, Ile-De-France and currently employs 22 full-time employees. The company went IPO on 2015-07-13. The firm is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and Age Related Macular Degeneration (ARMD). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.

Frequently asked questions about Biophytis

Analysts currently set an average price target of 0.02 EUR for the Biophytis stock (median: 0.02 EUR), implying -68.6 % versus the latest price. The consensus is based on 8 analyst ratings.

9 analysts currently rate the Biophytis stock: 8 recommend buying, 1 holding and 0 selling.

The Biophytis share (ALBPS.PA) is listed on 6 stock exchanges, including: London (0D1W.L), Frankfurt (6XB.F), München (6XB.MU), Düsseldorf (6XB.DU), Paris (ALBPS.PA).

The revenue cannot currently be calculated for Biophytis.

The expected profit of Biophytis is -11.18 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Biophytis is currently -0.03. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Biophytis stock.

The P/S cannot be calculated for Biophytis currently.

The Eulerpool Quality Score for Biophytis is 2/10.

The ISIN of Biophytis is FR001400OLP5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Biophytis is A14V4J. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Biophytis is ALBPS.PA. The ticker symbol is used to trade Biophytis shares on the stock exchange.

Fair ValueTerminal
0.04 EUR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
EUR
Initial public offering
Jul 13, 2015
ISIN
FR001400OLP5
Cusip
F52042102
Sedol
BYR4LH6
Market capitalization
52-Week Range
PEG
—
P/E ratio
P/Ee 2025
-0.03
P/Ee 2026
-0.03
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
0.04
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-5,964.94 %
Last updated Oct 11, 2026, 4:49 AM

Biophytis Ticker

DÜSSELDORF · 6XB.DUEURONEXT · ALBPS.PAFRANKFURT · 6XB.FLONDON · 0D1W.LMUNICH · 6XB.MUPARIS · ALBPS.PA

All fundamentals and in-depth analysis of Biophytis

Our stock analysis for Biophytis stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Biophytis. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.